ARF6 and breast carcinoma: As for the molecular mechanisms of the Arf6 pathway in invasion, we have shown previously that activation of Arf6 by GEP100, but not by other GEFs, perturbs E-cadherin-based cell-cell adhesion of breast cancer cells and may hence induce their motile phenotypes [23].